UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $133,000 | -81.9% | 14,036 | -67.8% | 0.00% | -100.0% |
| Q3 2021 | $734,000 | -8.9% | 43,628 | -17.3% | 0.00% | 0.0% |
| Q2 2021 | $806,000 | -53.3% | 52,774 | -40.4% | 0.00% | -66.7% |
| Q1 2021 | $1,726,000 | -26.2% | 88,599 | -31.7% | 0.00% | -25.0% |
| Q4 2020 | $2,338,000 | -21.8% | 129,741 | -16.2% | 0.00% | -55.6% |
| Q3 2020 | $2,988,000 | +76.4% | 154,910 | +138.8% | 0.01% | +12.5% |
| Q2 2020 | $1,694,000 | +333.2% | 64,872 | +195.7% | 0.01% | +166.7% |
| Q1 2020 | $391,000 | -58.3% | 21,942 | -21.9% | 0.00% | -50.0% |
| Q4 2019 | $938,000 | +10322.2% | 28,096 | +15508.9% | 0.01% | – |
| Q3 2018 | $9,000 | – | 180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |